Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mosapride Citrate for GI Motility After Laparoscopic Gastrectomy
NCT04493125Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Jul 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative ileus (POI) comparing Mosapride group with Placebo group (2 arms). Primary endpoint: The number of radiopaque markers transferred to the large intestine 3 days after surgery. Started Jul 2020; status: completed.
02
Drugs
mosapride
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT04493125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04493125.